Ângela Novais
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 52
- Endocrinology top 0.2%
- Enterobacteriaceae and Cronobacter Research 13
- Escherichia coli research studies 8
-
- Antibiotic Use and Resistance 6
- Pollution top 1%
- Pharmaceutical and Antibiotic Environmental Impacts 17
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 11
-
- Salmonella and Campylobacter epidemiology 8
-
- Bacterial biofilms and quorum sensing 7
- Co-authors
- Luı́sa PeixeTeresa M. CoqueRafael CantónFernando BaqueroElisabete MachadoCarla RodriguesAlessandra CarattoliLaurent Poirel
In The Last Decade
Ângela Novais
63 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Molecular Medicine 2.6k
- Endocrinology 1.4k
- Applied Microbiology and Biotechnology 252
- Pollution 836
- Clinical Biochemistry 357
Countries citing papers authored by Ângela Novais
This map shows the geographic impact of Ângela Novais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ângela Novais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ângela Novais more than expected).
Fields of papers citing papers by Ângela Novais
This network shows the impact of papers produced by Ângela Novais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ângela Novais. The network helps show where Ângela Novais may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ângela Novais, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 10 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 21 | |
| 13 | 2019 | 24 | |
| 14 | 2018 | 105 | |
| 15 | 2018 | 9 | |
| 16 | 2014 | 111 | |
| 17 | 2013 | 40 | |
| 18 | 2013 | 14 | |
| 19 | 2009 | 153 | |
| 20 | 2008 | 474 |
About Ângela Novais
Ângela Novais is a scholar working on Molecular Medicine, Endocrinology, Applied Microbiology and Biotechnology, Clinical Biochemistry and Pollution, having authored 65 papers that have together received 3.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (52 papers), Pharmaceutical and Antibiotic Environmental Impacts (17 papers), Enterobacteriaceae and Cronobacter Research (13 papers), Bacterial Identification and Susceptibility Testing (11 papers), Salmonella and Campylobacter epidemiology (8 papers), Escherichia coli research studies (8 papers), Bacterial biofilms and quorum sensing (7 papers) and Antibiotic Use and Resistance (6 papers). The work is most often cited by research in Molecular Medicine (2.6k citations), Endocrinology (1.4k citations), Applied Microbiology and Biotechnology (252 citations), Pollution (836 citations) and Clinical Biochemistry (357 citations). Ângela Novais has collaborated with scholars based in Portugal, Spain and Italy. Frequent co-authors include Luı́sa Peixe, Teresa M. Coque, Rafael Cantón, Fernando Baquero, Elisabete Machado, Carla Rodrigues, Alessandra Carattoli, Laurent Poirel, Ana Valverde and Johann Pitout. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.